Retacrit — Blue Cross Blue Shield of New Mexico
Anemia due to myelodysplastic syndrome
Initial criteria
- Length of approval depends on indication and plan type as specified
Approval duration
3mo–12mo depending on indication and plan
Anemia due to myelodysplastic syndrome
3mo–12mo depending on indication and plan